Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microplate Instruments Simplify Performance, Maximize Results for ELISA Applications

Published: Monday, November 18, 2013
Last Updated: Monday, November 18, 2013
Bookmark and Share
The Thermo Scientific Multiskan FC (IVD model) and Wellwash (IVD model) microplate instruments now conform to the European In Vitro Diagnostic Directive 98/79/EC and are available throughout Europe.

Microplate photometer and microplate strip washer provide a simple, modular solution to maximize results for routine enzyme-linked immunosorbent assays (ELISA) applications in diagnostic, as well as quality control laboratories.

“Researchers working in ELISA applications need simplified solutions that will help maximize their efforts and results,” said Hanna Granö-Fabritius, business director, sample preparation & analysis, Thermo Fisher Scientific. “Our instruments are critically important for vitro diagnostics use and lab managers can be assured that these products are compliant with the IVD Directive requirements. Our instruments are designed to offer convenience and reliability in clinical diagnostics and quality control laboratories to improve ease of use and accelerate results.”

Designed with 30 years’ experience in microplate photometry, the Thermo Scientific Multiskan FC instrument is a reliable and robust filter-based microplate photometer, measuring absorbance in the wavelength range of 340 to 850 nm. The Thermo Scientific Wellwash instrument is an easy-to-use microplate strip washer offering convenience and versatility ideal for routine assay runs. Both the Thermo Scientific Multiskan FC microplate photometer and Thermo Scientific Wellwash microplate strip washer are compact, simple and easy-to-use, enhancing ELISA productivity and throughput.

Features include:

• Large color display with a logical and intuitive graphical user interface for easy use and operation

• Internal software available eight different languages (English, French, German, Spanish, Portuguese, Russian, Japanese and Chinese) for regional customization

• USB ports for transferring data and protocols


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Thermo Fisher Scientific Facilities Achieve ISO 13485 Certification
The facilities in San Jose, CA and Franklin, MA have achieved the internationally recognized standard of quality management for the design and manufacture of medical devices.
Thursday, April 04, 2013
Thermo Fisher Scientific Reports Q3 Revenue and EPS Results
Revenue increased 5% to a record $3.09 billion for the third quarter with adjusted operating income rising 5% to $576 million.
Wednesday, October 24, 2012
Thermo Scientific Elects New Director to Board
Appointment of C. Martin Harris to Company’s board of directors.
Monday, March 26, 2012
Thermo Fisher Scientific Introduces Unity Lab Services
The new offering combines product and laboratory support services to create a single solution for customers to optimize productivity and reduce their total cost of laboratory operations.
Monday, January 09, 2012
Thermo Fisher Scientific Opens New Biomarker Translational Center
Goal is to accelerate MS-based biomarker discovery and its translation into development of routine clinical assays.
Wednesday, September 07, 2011
Scientific News
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!